Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vicky Roy

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Immunity|April 14, 2021
A Fc engineering approach to define functional humoral correlates of immunity against Ebola virusBronwyn M Gunn, Richard Lu, Matthew D Slein, et al.
JAMA Network Open|August 10, 2022
Durability of Heterologous and Homologous COVID-19 Vaccine BoostsC Sabrina Tan, Ai-Ris Y Collier, Jingyou Yu, et al.
Cell|August 20, 2021
Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egressLauren E Williamson, Kristen M Reeder, Kevin Bailey, et al.
Science Translational Medicine|June 12, 2020
Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody qualitySonia Maciejewski, Tracy J Ruckwardt, Kaitlyn M Morabito, et al.
Nature Biomedical Engineering|August 5, 2020
Integrated pipeline for the accelerated discovery of antiviral antibody therapeuticsPavlo Gilchuk, Robin G Bombardi, Jesse H Erasmus, et al.
Ebiomedicine|March 29, 2025
Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trialsChristopher L Cooper, Gavin Morrow, Maoli Yuan, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Immunity|April 14, 2021
A Fc engineering approach to define functional humoral correlates of immunity against Ebola virusBronwyn M Gunn, Richard Lu, Matthew D Slein, et al.
JAMA Network Open|August 10, 2022
Durability of Heterologous and Homologous COVID-19 Vaccine BoostsC Sabrina Tan, Ai-Ris Y Collier, Jingyou Yu, et al.
Cell|August 20, 2021
Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egressLauren E Williamson, Kristen M Reeder, Kevin Bailey, et al.
Science Translational Medicine|June 12, 2020
Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody qualitySonia Maciejewski, Tracy J Ruckwardt, Kaitlyn M Morabito, et al.
Nature Biomedical Engineering|August 5, 2020
Integrated pipeline for the accelerated discovery of antiviral antibody therapeuticsPavlo Gilchuk, Robin G Bombardi, Jesse H Erasmus, et al.
Ebiomedicine|March 29, 2025
Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trialsChristopher L Cooper, Gavin Morrow, Maoli Yuan, et al.
Pageof 3